Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Operating Expenses: 2010-2024

Historic Operating Expenses for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $2.6 million.

  • China Pharma Holdings' Operating Expenses rose 0.51% to $568,491 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 4.43%. This contributed to the annual value of $2.6 million for FY2024, which is 5.36% up from last year.
  • Per China Pharma Holdings' latest filing, its Operating Expenses stood at $2.6 million for FY2024, which was up 5.36% from $2.5 million recorded in FY2023.
  • Over the past 5 years, China Pharma Holdings' Operating Expenses peaked at $4.5 million during FY2020, and registered a low of $2.5 million during FY2023.
  • Over the past 3 years, China Pharma Holdings' median Operating Expenses value was $2.6 million (recorded in 2024), while the average stood at $2.7 million.
  • In the last 5 years, China Pharma Holdings' Operating Expenses crashed by 79.30% in 2020 and then rose by 5.36% in 2024.
  • Over the past 5 years, China Pharma Holdings' Operating Expenses (Yearly) stood at $4.5 million in 2020, then fell by 29.16% to $3.2 million in 2021, then dropped by 4.82% to $3.1 million in 2022, then declined by 19.13% to $2.5 million in 2023, then increased by 5.36% to $2.6 million in 2024.